ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 629 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 629; 2) Community: the network communities that were significantly associated with the response to NSC 629; 3) Molecule: the relationships between components within communities and NSC 629; 4) MDR: the compounds that were significantly associated with the NSC 629.

NSC Compound Enrichment Correlation
NSC 652168 Null 0.0174989034030623 0.15249943
NSC 661421 Null 0.0174989034030623 -0.12660738
NSC 667904 1-(8-(2,3-dimethoxyphenyl)-7-methyl-7,8-dihydro-6H-[1,3]dioxolo[4,5-g]chromen-6-yl)-2-phenylhydrazine 0.0174989034030623 0.1203618
NSC 670765 Null 0.0174989034030623 -0.1331496
NSC 681645 Camptothecin Derivative 0.0174989034030623 0.52536065
NSC 700089 Diazonamide A 0.0174989034030623 0.10011112
NSC 701378 3-Pyridinecarbonitrile, 4-(4-chlorophenyl)- 6-[4-[[7-(trifluoromethyl)-4-quinolinyl]amino]phenyl]- 1,2-dihydro-2-oxo- 0.0174989034030623 0.26362228
NSC 724994 2-[(Dimethylamino)-1-ethyl]-5,6-dihydro-2,3-dimethoxy-8,9-me thylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Formic Acid 0.0174989034030623 0.49727441
NSC 730478 16-[4-{(3-Imidazol-1-yl)propoxy}-3-methoxybenzylidene]-5-androsten-3.beta.,17.beta.-diol 0.0174989034030623 -0.083470528
NSC 751465 Null 0.0174989034030623 0.1364425
Total:43  Current:13    [First] [Prev] [Next] [Last]